Strattera
Attention Deficit Hyperactivity Disorder
Treatment
1 FDA approval
20 Active Studies for Strattera
Treatment for
Attention Deficit Hyperactivity Disorder
What is Strattera
Atomoxetine
The Generic name of this drug
Treatment Summary
Atomoxetine is a medication used to treat attention deficit hyperactivity disorder (ADHD). It is known by the brand name Strattera and works by increasing norepinephrine and dopamine in the brain to reduce symptoms associated with ADHD such as distractibility, hyperactivity, and impulsivity. Atomoxetine has fewer side effects than traditional stimulant medications used to treat ADHD and is considered a safer option for those at risk of substance abuse. It can be used in combination with other treatments such as psychological therapy and cognitive behavior therapy. Atomoxetine is typically used in adults and children who cannot take stimulant medications.
Strattera
is the brand name
Strattera Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Strattera
Atomoxetine
2002
183
Approved as Treatment by the FDA
Atomoxetine, commonly known as Strattera, is approved by the FDA for 1 uses like Attention Deficit Hyperactivity Disorder .
Attention Deficit Hyperactivity Disorder
Helps manage Attention Deficit Hyperactivity Disorder (ADHD)
Effectiveness
How Strattera Affects Patients
Atomoxetine is a drug used to treat Attention Deficit Hyperactivity Disorder (ADHD). It works by increasing the levels of certain chemicals in the brain which can improve symptoms. Taking atomoxetine can increase blood pressure and heart rate, so caution should be taken in patients with conditions like hypertension or cardiovascular disease. It may also cause manic or psychotic symptoms in some cases, or increase the risk of suicidal thoughts. Atomoxetine may also cause severe liver injury, and should not be taken if there are any signs of liver dysfunction.
How Strattera works in the body
Atomoxetine is a medicine used to treat ADHD. It works by blocking the norepinephrine transporter and serotonin transporter, which prevents the reuptake of norepinephrine and serotonin in the brain. This is thought to improve the symptoms of ADHD. Recent studies using positron emission tomography (PET) imaging have also shown that atomoxetine blocks the N-methyl-d-aspartate receptor, which suggests it might also affect the glutamate system within the brain.
When to interrupt dosage
The prescribed dosage of Strattera is dependent upon the determined affliction. The quantity of dosage varies, conforming to the method of administration described in the following table.
Condition
Dosage
Administration
Attention Deficit Hyperactivity Disorder
, 10.0 mg, 18.0 mg, 25.0 mg, 40.0 mg, 60.0 mg, 80.0 mg, 100.0 mg
Oral, Capsule, Capsule - Oral, , Kit, Kit - Oral
Warnings
Strattera has seven contraindications. Therefore, it should not be administered concurrently with any of the conditions presented in the following table.
Strattera Contraindications
Condition
Risk Level
Notes
Cardiovascular Diseases
Do Not Combine
advanced arteriosclerosis
Do Not Combine
Hypertensive disease
Do Not Combine
Pulse Frequency
Do Not Combine
Pheochromocytoma
Do Not Combine
Hyperthyroidism
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Atomoxetine may interact with Pulse Frequency
There are 20 known major drug interactions with Strattera.
Common Strattera Drug Interactions
Drug Name
Risk Level
Description
Amoxapine
Major
The metabolism of Amoxapine can be decreased when combined with Atomoxetine.
Astemizole
Major
The metabolism of Astemizole can be decreased when combined with Atomoxetine.
Clonidine
Major
The metabolism of Clonidine can be decreased when combined with Atomoxetine.
Erlotinib
Major
The metabolism of Erlotinib can be decreased when combined with Atomoxetine.
Hydroxyzine
Major
The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Hydroxyzine.
Strattera Toxicity & Overdose Risk
There have been fatalities reported from mixing atomoxetine with other drugs, but no deaths from taking too much atomoxetine alone. If an overdose is suspected, people may experience seizures, stomach issues, sleepiness, dizziness, shaking, or abnormal behavior. They may also have an increased heart rate, widened pupils, dry mouth, hyperactivity, or agitation. Rarely, people have experienced a prolonged heartbeat, confusion, or hallucinations. If an overdose is suspected, contact a poison control center for advice. Dialysis is not likely to help with an atomoxetine overdose.
Strattera Novel Uses: Which Conditions Have a Clinical Trial Featuring Strattera?
77 active clinical trials are currently examining the potential of Strattera to alleviate Attention Deficit Hyperactivity Disorder.
Condition
Clinical Trials
Trial Phases
Attention Deficit Hyperactivity Disorder
63 Actively Recruiting
Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2
Strattera Reviews: What are patients saying about Strattera?
5
Patient Review
3/21/2022
Strattera for Attention Deficit Disorder with Hyperactivity
4
Patient Review
5/8/2022
Strattera for Attention Deficit Disorder with Hyperactivity
3.7
Patient Review
4/12/2022
Strattera for Attention Deficit Disorder with Hyperactivity
3.3
Patient Review
5/4/2022
Strattera for Attention Deficit Disorder with Hyperactivity
3
Patient Review
7/12/2022
Strattera for Attention Deficit Disorder with Hyperactivity
2.3
Patient Review
2/27/2022
Strattera for Attention Deficit Disorder with Hyperactivity
2.3
Patient Review
12/22/2021
Strattera for Attention Deficit Disorder with Hyperactivity
2.3
Patient Review
7/6/2022
Strattera for Attention Deficit Disorder with Hyperactivity
2
Patient Review
10/2/2022
Strattera for Attention Deficit Disorder with Hyperactivity
1
Patient Review
6/12/2022
Strattera for Attention Deficit Disorder with Hyperactivity
Patient Q&A Section about strattera
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What does Strattera make you feel like?
"The most commonly reported side effects of Strattera are nausea, vomiting, abdominal pain, decreased appetite, constipation, headache, dry mouth, tiredness, and sleepiness. Strattera has been associated with an increased risk of suicidal thoughts or behavior in children and adolescents with ADHD."
Answered by AI
Is Strattera a stimulant or depressant?
"Strattera is a medication used to treat symptoms of attention deficit hyperactivity disorder (ADHD or ADD), including distractibility, impulsivity, and hyperactivity, in children, teens, and adults."
Answered by AI
What does Strattera do to you?
"Strattera works by increasing the amount of norepinephrine, an important chemical in the brain, which appears to help ADHD by increasing attention span and reducing impulsive behavior and hyperactivity."
Answered by AI
Is Strattera and Adderall the same thing?
"Both Strattera and Adderall are effective for treating ADHD; however, Strattera does not contain amphetamine, which means it is less likely to be abused or cause dependence, tolerance, or withdrawal symptoms on discontinuation."
Answered by AI